HP Xenon-129 fMRI of Healthy Volunteers and Participants With Alzheimer's Disease
Status:
Unknown status
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
This study involves imaging participants' brains using MRI. The goal is to develop a
high-resolution, high-sensitivity imaging tool, hyperpolarized xenon functional brain
magnetic resonance imaging, which can provide more sensitive measurement of brain function,
facilitating the development of drugs for more successful treatment of Alzheimer's disease.
Phase:
Early Phase 1
Details
Lead Sponsor:
Thunder Bay Regional Research Institute
Collaborators:
Lakehead University St. Joseph's Care Group Thunder Bay Regional Health Sciences Centre